# Code-Portfolio

<a href="https://www.sas.com/en_us/software/viya.html">
    <img src="https://img.shields.io/badge/SAS%20Viya-3.4+-blue.svg?&colorA=0b5788&logoWidth=30&logo=data:image/png;base64,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"
        alt="SAS Viya Version"/>
  </a>
  
  ![](https://img.shields.io/badge/R-276DC3?style=for-the-badge&logo=r&logoColor=white)

This portfolio contains some of my coding in R and SAS for more recent research projects. Some of these projects are still ongoing, so please do not copy or share these code outside of the purposes to review my coding skills and abilities.


## Table of some recent projects and associated code or code snippets
| Project Name  | Project Description | Coding Language |
| ------------- | ------------- | ------------- |
| ü¶ü [Yellow Fever Vaccinations](/Yellow-Fever-Models.Rmd)  | Our team created a multi-host SEIR model to simulate a YFV outbreak and the impacts of vaccination on short and long-term epidemic transmission dynamics. My role specifically was conceptualizing the mathematical models and all the coding in R |  R |
| üíâ [Delayed Vaccinations](/VaxStudy.sas)  | Ongoing ecological study to understand the impacts of delayed vaccinations in low and lower-middle income countries. I am responsible for collaborating on the study design and leading the data analysis and coding. Part of the project is also being completed in R. This portion is just one piece of the larger code. | SAS |
| üè• [NYC COVID-19 Hospitalizations](/NYC-COVID-Hospitalizations.sas)  | One part of a larger midterm where we looked at NYC COVID-19 hospitalizations. The data was pulled directly from the NYC Health GitHub | SAS  |
| ü§ß [Ebola Transmission Dynamics](/Ebola-Model.R)  | Simulated the transmission dynamics of the 2014 West African Ebola Outbreak overall and by countries affected (Guinea, Liberia, and Sierra Leone | R  |
| üíâ [Vaccine Uptake and Insurance Coverage](/Vax-Uptake-NHANES.sas)  | Looking at the impact of insurance coverage on Hep A, Hep B, and HPV vaccine uptake using two cycles of NHANES. I primarily did all the analysis and the first run of the SAS code and annotations. | SAS  |
| üíä [PrEP Uptake among cis-gender Black women](/PrepUptake-MetaAnalysis.R)  | A systematic review and proportional meta-analysis on observational studies looking at knowledge of and willingness to uptake PrEP among cis-gender Black women in America. My role was to code and run the meta-analysis. | R |

## Geospaital Studies
### Methods of Predicting Tick Density
![combo](https://user-images.githubusercontent.com/99552141/185223019-846b5fca-93eb-4e7e-b571-755bb4b108e0.png)
For this mini project, I used data from a previous study by [Diuk-Wasser and colleagues](https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1466-8238.2010.00526.x). I compared predicted *Ixodes scapularis* nymphs density to observed density between 2004-2006 in the United States. I compared two methods of prediction: density interpolated by inverse distance weighting (IDW) [Figure A] and density predicted by zero-inflated negative binomial model [Figure B].

The formula for basic IDW interpolation of $i^th$ area $x$:

```math
x_i=(1/d_1  x_1+1/d_2  x_2+‚ãØ1/d_n  x_n)/(1/d_1 +1/d_2 +‚ãØ1/d_n )
```

Where $1/d_1$  is the inverse of the distance from point 1 to the predicted $i^th$ area and $x_1$ is the observed density at point 1. 

In comparison, the regression model predicts density based on several ecological predictors. The regression model is a combination of a logistic regression model predicting whether the observation was sampled from the point mass at zero. The second part of the model estimates the expected value based on the predictors (i.e., $Œ≤ ÃÇ_n x_n$)

```math
Y ÃÇ=(P ÃÇ )(0)+(1-P ÃÇ )[exp‚Å°(Œ≤ ÃÇ_0+Œ≤ ÃÇ_1 x_1+Œ≤ ÃÇ_2 x_2+‚ãØ)]
P ÃÇ=exp‚Å°(Œ≥ ÃÇ_0+Œ≥ ÃÇ_1 z_1+Œ≥ ÃÇ_2 z_2+‚ãØ)/[1+exp‚Å°(Œ≥ ÃÇ_0+Œ≥ ÃÇ_1 z_1+Œ≥ ÃÇ_2 z_2+‚ãØ)]
```

While the model was built and trained based on the observed data, it still will generate the expected density based on the predictors. Therefore, in areas such as Minnesota, where there are small patches of high density. The model estimates that this area would have low density based on the model predictors. In comparison, the IDW method estimates this area to have a patch of high density because the observed data had a patch of high density.

### SARS-CoV-2 Spillback in White Tail Deer
In this concept proposal, I would be looking at the spillback tranmission dynamics of SARS-CoV-2 from humans to white tail deer (WTD) in New York State following some previoulsy published work. The GIS-portion of this proposal included creating geospaital views of the sampling areas and sampling grids.
![FullMap](https://user-images.githubusercontent.com/99552141/185225910-9db2776c-b7ab-4bf3-8066-19427137070b.png)
![SamplingHarriman](https://user-images.githubusercontent.com/99552141/185225956-b0a50968-ad04-4aa1-84f3-620e55d4c4bf.png)


## Publications List
1. Kakabadze Z, Kipshidze N, Paresishvili T, Kipshidze N, Vadachkoria Z, Chakhunashvili D. Human Placental Mesenchymal Stem Cells for the Treatment of ARDS in Rat. Stem Cells Int. 2022
2. Kipshidze N, Kipshidze N, Fried M. COVID-19 Vaccines: Special Considerations for the Obese Population. Obes Surg. 2021.
3. Fried M, Kipshidze N, Sramkrova P, et al. Metabolic Outcomes of Percutaneous Transcathether Bariatric Embolotherapy: Insights from an RCT. Obes Surg. 2021.
4. Kipshidze NN, Kipshidze N, Horn JB. Transcatheter Endoluminal Phototherapy as a Possible Adjunct Treatment for Patients with COVID-19. Photobiomodul Photomed Laser Surg. 2020;38(10):579-580.
5. Kipshidze N, Iversen P, Porter TR, Kipshidze N, Siddiqui F, Dangas G, Jawed F. Targeted, Site-Specific, Delivery Vehicles of Therapeutics for COVID-19 Patients. Brief Review. Clin Appl Thromb Hemost. 2020;26:1076029620954911.
6. Kipshidze N, Yeo N, Kipshidze N. Photodynamic and sonodynamic therapy of acute hypoxemic respiratory failure in patients with COVID-19. Nature Photonics. 2020.
7. Kipshidze N, Dangas G, White CJ, Kipshidze N, Siddiqui F, Lattimer C, Carter C, Fareed J. Viral Coagulopathy in Patients With COVID-19: Treatment and Care. Clin Appl Thromb Hemost. 2020;26:1076029620936776.
8. Kipshidze N, Chekanov VS, Kipshidze N, Reddy VY, Dangas G. Transpulmonary electrotherapy for reduction of lung viral load of SARS-CoV-2 in patients with COVID-19. Med Hypotheses. 2020;143:110071.
9. Kipshidze N., Kipshidze N. Catheter-Based, Local Therapy in SARS-CoV-2 Patients? BMJ 2020. 
10. Reddy, V. Y., P. Neuzil, D. Musikantow, P. Sramkova, R. Rosen, N. Kipshidze, N. Kipshidze and M. Fried. Transcatheter Bariatric Embolotherapy for Weight Reduction in Obesity. J Am Coll Cardiol. 2020;76(20):2305-2317.
11. Reddy V., Abbo A., Ruiz C., Kerner A., Kreidel F., Topilsky Y., Kipshidze N., Avisar N., Kronzon I., Petru J., Neuzil P. First-in-Human Percutaneous, Circumferential Annuloplasty for Functional TR. JACC Case Reports. 2020: 2(14): 2176‚Äì2182
12. Lutz, C. S., M. P. Huynh, M. Schroeder, S. Anyatonwu, F. S. Dahlgren, G. Danyluk, D. Fernandez, S. K. Greene, N. Kipshidze, L. Liu, O. Mgbere, L. A. McHugh, J. F. Myers, A. Siniscalchi, A. D. Sullivan, N. West, M. A. Johansson, and M. Biggerstaff. Applying infectious disease forecasting to public health: a path forward using influenza forecasting examples. BMC Public Health 2019; 19(1): 1659.
13. Fried M, Kipshidze N. Response to Letter to the Editor: Left Gastric Artery Embolization for Weight Loss-a Dead-End Procedure. Obes Surg 2019; 29(6): 1939-41.
14. Kipshidze N, Prakash A, Kipshidze N, Chakhunashvili D, Kakabadze Z: A Novel Endoscopic Bariatric Procedure: Results of an Experimental Study. Obes Surg 2016, 26(12):3058-3065.
15. Kakabadze Z, Kipshidze N, Mardaleishvili K, Chutkerashvili G, Chelishvili I, Harders A, Loladze G, Shatirishvili G, Kipshidze N, Chakhunashvili D et al: Phase 1 Trial of Autologous Bone Marrow Stem Cell Transplantation in Patients with Spinal Cord Injury. Stem Cells Int 2016, 2016:6768274.
16. Kipshidze N, Platonova E, DiNicolantonio JJ, Kuliczkowski W, Serebruany VL: Excessive long-term platelet inhibition with prasugrel or ticagrelor and risk of infection: another hidden danger? Am J Ther 2015, 22(2):e22-27.
17. Can MM, Guler G, Guler E, Ozveren O, Turan B, DiNicolantinio JJ, Kipshidze N, Serebruany V: Enhanced platelet reactivity in pediatric depression: an observational study. Blood Coagul Fibrinolysis 2015, 26(7):731-735.
18. Serebruany VL, Pokov AN, Aradi D, Can M, DiNicolantonio J, Kipshidze N, Atar D: Effect of aliskiren and valsartan combination versus aliskiren monotherapy on hemostatic biomarkers in hypertensive diabetics: Aliskiren and Valsartan Impact in Diabetics pilot trial. Am J Ther 2014, 21(6):482-490.
19. Serebruany VL, Kipshidze N, Pershukov IV, Kuliczkowski W, Carnes J, Atar D: Fatal sepsis and systemic inflammatory response syndrome after off-label prasugrel: a case report. Am J Ther 2014, 21(6):e229-233.
20. Rukhadze L, Kipshidze N, Archvadze A, Kaloiani V, Kipshidze N, Lapiashvili E: Clinical neurological dynamic after intervention treatment in patient with multiple sclerosis (MS). Journal of the Neurological Sciences 2013(333):411.
21. Kipshidze N, Rukhadze I, Archvadze A, Kipiani V, Kipshidze N, Lapiashvili E, Kaloiani V: Endovascular treatment of patients with chronic cerebrospinal venous insufficiency and Multiple sclerosis. Georgian Med News 2011(199):29-34.
22. Kipshidze N. Does over-exuberance affect the orbitofrontal cortex and/or anterior cingulated cortex differently during decision-making? Cardiology and Internal Medicine 2010(12):114-118

## Recent Conference Abstracts and Posters
1.	Kipshidze, N., Kakabadze, Z., Janelidze, N., Kipshidze, N., & Rosen, R. (2020). Associations Between Tumor Feeding Intra-arterial Pressure And Interstitial Fluid Pressure Of Solid Tumors: Intraoperative Findings ECIO Virtual: Interventional Oncology,  
2.	Kipshidze, N., White, C., Kipshidze, N., Reddy, V., & Dangas, G. (2020). Transcatheter Therapies for COVID-19. TCT Connect
3.	Reddy, V., Fried, M., Neuzil, P., Rosen, R., Sramkova, P., Kipshidze, N., & Kipshidze, N. (2020). Percutaneous Transcatheter Bariatric Embolotherapy For Weight Loss In Obesity: Two Year Data From A Prospective RCT. ESC Congress, 
4.	Fried, M., Reddy, V., Neuzil, P., Rosen, R., Sramkova, P., Kipshidze, N., & Kipshidze, N. (2020). Metabolic Changes Following Transcatheter Bariatric Embolotehrapy for Weight Loss in Obesity: Secondary Outcomes from a Prospective RCT. ESC Congress,  
5.	Reddy, V., Fried, M., Neuzil, P., Rosen, R., Sramkova, P., Kipshidze, N., & Kipshidze, N. (2020). Efficacy and safety of bariatric embolotherapy for weight management in people with obesity: Late-breaking findings from a prospective RCT. EuroPCR, 
6.	Reddy, V., Rosen, R., Fried, M., Neuzil, P., Sramkova, P., Kipshidze, N., & Kipshidze, N. (2020). Assessing the safety and efficacy of transcatheter bariatric emboloterhapy for weight loss in obese patients: Results from a randomized, sham-controlled clinical trial. CIRSE 2020 Summit.

